Carnitine metabolism and deficit--when supplementation is necessary?

Area of Science:

• Biochemistry
• Metabolic Disorders
• Cellular Biology

Background:

• Carnitine is an amino acid derivative crucial for energy metabolism, particularly in high-demand tissues.
• It plays a key role in the beta-oxidation of long-chain fatty acids within mitochondria.
• Carnitine regulates Coenzyme A (CoA) concentration and removes toxic acyl groups, preventing metabolic pathway inhibition.

Purpose of the Study:

• To review the essential role of carnitine in intermediary metabolism.
• To discuss the causes and consequences of primary and secondary carnitine deficiency.
• To explore the therapeutic applications of L-Carnitine in various medical conditions.

Main Methods:

• Literature review of carnitine's metabolic functions.
• Analysis of causes for primary and secondary carnitine deficiency.
• Summary of clinical observations and therapeutic uses of L-Carnitine.

Main Results:

• Primary carnitine deficiency stems from defects in the plasma membrane carnitine transporter.
• Secondary deficiency is linked to inborn errors of metabolism, medications (valproate, zidovudine), chronic diseases (cirrhosis, renal failure, diabetes, heart failure, Alzheimer's), critical illness, and preterm neonates.
• Carnitine stabilizes cell membranes and enhances red blood cell osmotic resistance.

Conclusions:

• Carnitine deficiency, though primary forms are rare, can arise from diverse secondary causes impacting fatty acid metabolism.
• L-Carnitine administration shows potential therapeutic benefits across a spectrum of conditions, including neurological, cardiovascular, and metabolic diseases.
• Understanding carnitine's multifaceted role is essential for managing metabolic health and exploring novel therapeutic strategies.